Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 1070


Functional Polymorphisms of CTLA4 Associated with Aggressive Periodontitis in the Chinese Han Population.

He F, Zhou Y, Wang X, Li L, Geng Y, Wang Z, Wang Y, Xu Y.

Cell Physiol Biochem. 2018;50(3):1178-1185. doi: 10.1159/000494544. Epub 2018 Oct 24.


Correlation between CTLA4 genetic polymorphisms, its serum protein level and the susceptibility to recurrent spontaneous abortion: A case-control study.

Li L, Liu J, Qin S, Li R.

Medicine (Baltimore). 2018 Oct;97(42):e12754. doi: 10.1097/MD.0000000000012754.


Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population.

Su J, Li Y, Su G, Wang J, Qiu T, Ma R, Zhao L.

Medicine (Baltimore). 2018 Jul;97(29):e11422. doi: 10.1097/MD.0000000000011422.


A meta-analysis of the association between CTLA-4 genetic polymorphism and susceptibility of asthma.

Zheng Y, Wang H, Luo L, Liao L, You L, Wang J, Li Q.

Medicine (Baltimore). 2018 Jul;97(28):e11380. doi: 10.1097/MD.0000000000011380. Review.


Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk.

Zhang Y, Zhang S, Xia W, Dong Z.

J Cancer Res Ther. 2018 Jun;14(Supplement):S526-S532. doi: 10.4103/0973-1482.191065.


Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population.

Dursun HG, Yılmaz HO, Dursun R, Kulaksızoğlu S.

J Immunol Res. 2018 Apr 23;2018:1643906. doi: 10.1155/2018/1643906. eCollection 2018.


Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.

Fang M, Huang W, Mo D, Zhao W, Huang R.

Cell Physiol Biochem. 2018;47(1):414-427. doi: 10.1159/000489953. Epub 2018 May 18.


CTLA‑4 interferes with the HBV‑specific T cell immune response (Review).

Cao H, Zhang R, Zhang W.

Int J Mol Med. 2018 Aug;42(2):703-712. doi: 10.3892/ijmm.2018.3688. Epub 2018 May 17. Review.


Associations of CTLA4 +49 A/G Dimorphism and HLA-DRB1*/DQB1* Alleles With Type 1 Diabetes from South India.

Padma-Malini R, Rathika C, Ramgopal S, Murali V, Dharmarajan P, Pushkala S, Balakrishnan K.

Biochem Genet. 2018 Oct;56(5):489-505. doi: 10.1007/s10528-018-9856-7. Epub 2018 Mar 30.


CTLA-4 Polymorphisms in Patients with IgA Nephropathy Correlate with Proteinuria.

Jacob M, Ohl K, Goodarzi T, Harendza S, Eggermann T, Fitzner C, Hilgers RD, Bolte A, Floege J, Rauen T, Tenbrock K.

Kidney Blood Press Res. 2018;43(2):360-366. doi: 10.1159/000488069. Epub 2018 Mar 8.


Distribution of Cytotoxic T Lymphocyte-Associated Antigen-4 Promoter Polymorphisms in Taiwanese Patients with Type 2 Diabetes Mellitus.

Shih YL, Lu HF, Hsiao CW, Ho KT, Chen PC, Huang CN, Chang Y, Kao SJ, Shiau MY, Chang YH.

Int J Med Sci. 2018 Feb 12;15(4):395-402. doi: 10.7150/ijms.23097. eCollection 2018.


Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.

Hu Y, Xu K, Jiang L, Zhang L, Shi H, Cui D.

Genet Test Mol Biomarkers. 2018 Apr;22(4):224-236. doi: 10.1089/gtmb.2017.0243. Epub 2018 Feb 20.


CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.

Hammrich J, Wittig S, Ernst T, Gruhn B.

J Cancer Res Clin Oncol. 2018 Mar;144(3):587-592. doi: 10.1007/s00432-018-2578-8. Epub 2018 Jan 15.


The expression of mCTLA-4 in skin lesion inversely correlates with the severity of psoriasis.

Liu P, He Y, Wang H, Kuang Y, Chen W, Li J, Chen M, Zhang J, Su J, Zhao S, Chen M, Tao J, Chen X, Zhu W.

J Dermatol Sci. 2018 Mar;89(3):233-240. doi: 10.1016/j.jdermsci.2017.11.007. Epub 2017 Nov 22.


CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.

Qin XY, Lu J, Li GX, Wen L, Liu Y, Xu LP, Chang YJ, Liu KY, Jiang ZF, Huang XJ.

Ann Hematol. 2018 Mar;97(3):485-495. doi: 10.1007/s00277-017-3203-7. Epub 2017 Dec 21.


Analysis of CTLA-4+49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran.

Almasi S, Aliparasti MR, Naghili B, Yeganeh K, Rahnama B, Tavanafar F, Hazhir Karzar B, Amini Khiabani S, Naghili A, Babaloo Z.

Infect Genet Evol. 2018 Jan;57:121-127. doi: 10.1016/j.meegid.2017.11.001. Epub 2017 Nov 20.


CD25-expressing Th17 cells mediate CD8+ T cell suppression in CTLA-4 dependent mechanisms in pancreatic ductal adenocarcinoma.

Lang C, Wang J, Chen L.

Exp Cell Res. 2017 Nov 15;360(2):384-389. doi: 10.1016/j.yexcr.2017.09.030. Epub 2017 Sep 20.


CTLA-4-expression on VZV-specific T cells in CSF and blood is specifically increased in patients with VZV related central nervous system infections.

Schub D, Fousse M, Faßbender K, Gärtner BC, Sester U, Sester M, Schmidt T.

Eur J Immunol. 2018 Jan;48(1):151-160. doi: 10.1002/eji.201747079. Epub 2017 Sep 14.


Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

Gallardo D, Bosch-Vizcaya A, Rodríguez-Romanos R, Santos N, Buño I, de la Cámara R, Brunet S, Jiménez-Velasco A, González M, Nieto JB, Martínez-Laperche C, Vallejo C, Ferrá C, Sampol A, López-Jiménez J, Pérez-Simón JA, Martínez C, Díez JL; GvHD/Immunotherapy Committee of the Spanish Hematopoietic Transplant Group.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2042-2047. doi: 10.1016/j.bbmt.2017.08.003. Epub 2017 Aug 4.


-318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.

Oliveira VB, Dezan MR, Gomes FCA, Menosi Gualandro SF, Krieger JE, Pereira AC, Marsiglia JD, Levi JE, Rocha V, Mendrone-Junior A, Sabino EC, Dinardo CL.

Int J Immunogenet. 2017 Oct;44(5):219-224. doi: 10.1111/iji.12334. Epub 2017 Aug 17.


Supplemental Content

Support Center